Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT02939274

Unknown

An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer

Metastatic Breast Cancer
NCT00167414

Completed

Study for Using Radiosurgery on Limited Metastases of Breast Cancer

Breast Cancer, Metastatic
NCT02792725

Approved for marketing

Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer

Metastatic Breast Cancer
NCT02088710

Unknown

Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer

Female Breast Cancer
NCT03080428

Withdrawn

Assessment of Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in ER-positive, Her2-negative Early Breast Cancer (OPTIGEN)

ER-positive Her2-negative Early Breast Cancer
NCT00156273

Completed

Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer

Metastatic Breast Cancer
NCT00176046

Completed

Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study

Metastatic Breast Cancer
NCT03115658

Completed

Physical Activity and First Degree Female Relatives of Breast Cancer Patients

Female | First-degree Relative With Breast Cancer
NCT02144012

Terminated

A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus the Combination of Trastuzumab Plus Docetaxel in Patients With HER2-positive Breast Cancer

Metastatic Breast Cancer
NCT01320111

Completed

Breast Cancer Study: Paclitaxel Versus Paclitaxel Plus Sorafenib in Second- or Third-line Treatment (PASO)

Metastatic Breast Cancer
NCT02875951

Unknown

Investigating Patient Satisfaction With Oral Anti-cancer Treatment in Patients With Hormone-receptor Positive, HER2-receptor Negative, Advanced Breast Cancer (IPSOC-mamma)

ER Positive, HER2 Negative Breast Cancer Neoplasms
NCT01528345

Terminated

Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer

Metastatic Breast Cancer
NCT01202591

Completed

Safety and Efficacy of AZD4547 in Combination With Fulvestrant vs. Fulvestrant Alone in ER+ Breast Cancer Patients (GLOW)

FGFR Inhibition, Pharmacokinetics, Biomarkers | ER+ Breast Cancer
NCT01773460

Terminated

Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane (Evelyn)

Metastatic Breast Cancer
NCT01561443

Completed

LINE: Treatment Patterns in postmenopausaL Women With Hormone Receptor Positive Breast Cancer (LINE)

Local Advanced or Metastatic Postmenopausal Breast Cancer
NCT02207335

Unknown

Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer

Metastatic Breast Cancer
NCT00807781

Completed

Mammaglobin-A DNA Vaccine for Metastatic Breast Cancer

Metastatic Breast Cancer
NCT01597999

Unknown

Benefits of Breast MRI for Predicting of Histopathologic Cell Type of Small Breast Cancer

Invasive Breast Cancer
NCT01433926

Completed

Characteristics of Disseminated Her2+ Breast Cancer Patients Treated With Trastuzumab That Have Reached Complete, Partial Remission or Stabilization of Disease During More Than 3 Years (LongHer)

HER-2 Positive Breast Cancer
NCT00328120

Completed

Faslodex 500mg Multiple Dose Tolerability Study in BC Patients

Advanced Breast Cancer
NCT00334802

Completed

Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer

Metastatic Breast Cancer
NCT00286247

Completed

Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer

Locally Advanced Breast Cancer (LABC)
NCT07596212

Not yet recruiting

BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder

Breast Cancer | Hypoactive Sexual Desire Disorder | Hormone Receptor Positive Breast Carcinoma | Early-stage Breast Cancer
NCT06781996

Recruiting

A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer (HOPE)

Breast Cancer | Breast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT07019740

Completed

Evaluatıon of sympathetıc Nervous System fındıngs and theır relatıonshıp wıth Symptoms ın patıents wıth Breast Cancer Related Lymphedema

Lymphedema, Breast Cancer
NCT07014657

Completed

Effect of Digital Combined Decongestive Therapy in Patients With Breast Cancer-related Lymphedema: a Follow-up Study

Breast Cancer-Related Lymphedema
NCT03295695

Withdrawn

PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient

Breast Cancer | Breast Neoplasms | Breast Cancer, Male | Breast Cancer, Female
NCT07599618

Not yet recruiting

Evaluation of a Patient-Centered Decision-Making Support Tool for Older Adults With Advanced Breast Cancer and Their Care Partners (PCDM)

Metastatic Breast Cancer
NCT07593196

Not yet recruiting

HER2-positive Metastatic Breast Cancer in Kazakhstan

Metastatic Breast Cancer
NCT07579286

Recruiting

Refusal of Sentinel Lymph Node Biopsy in Patients With Luminal A Subtype Early Breast Cancer (LumiNOde)

Early Breast Cancer
NCT07580833

Not yet recruiting

A Study to Investigate the Effect of Food on the Bioavailability of Oral Paclitaxel Administered With Encequidar in Participants With Advanced Solid Tumors

Metastatic Breast Cancer
NCT07523607

Not yet recruiting

FAP PET/CT for Staging Patients With Breast Cancer

Breast Cancer Detection
NCT07469267

Recruiting

Level I-II Axillary Irradiation in Breast Cancer With Sentinel-Node Macro-metastases (RELAX)

Breast Cancer | Radiotherapy
NCT07393425

Recruiting

Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast Cancer

HER2 + Breast Cancer
NCT07368543

Not yet recruiting

Sequencing SG vs. T-DXd in HER2-Low/TROP2-High Metastatic Breast Cancer (STORM)

Metastatic Breast Cancer
NCT07364760

Not yet recruiting

The Effect of Group and Mobile Wellness Coaching Given to Women With Breast Cancer on the Disease

Breast Cancer Females
NCT07331363

Recruiting

Evaluation of the Effect of Using Ultrasound Robots for Breast Cancer Screening: A Multicenter, Parallel-group, Cluster Randomized Controlled Trial

Breast Cancer | Ultrasound
NCT07310420

Recruiting

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer

Advanced Breast Cancer
NCT07294534

Not yet recruiting

A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX87in Combination With HLX22 or Pertuzumab in the Neoadjuvant Therapy of HER2-Positive Bresat Cancer

HER2 + Breast Cancer
NCT07266194

Not yet recruiting

The Study Will Enroll Females Who Are Coming in for Their Annual Mammogram Screening and Who Are Schedule for a Biopsy to Provide a Breath Sample Via a Mask to Evaluate if Breast Cancer Can be Detected.

Breast Cancer Detection
NCT07179809

Not yet recruiting

Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer

Metastatic Breast Cancer
NCT06070324

Not yet recruiting

Effect of Suture Material on Postoperative Nipple Areolar Complex Widening

Breast Cancer | Gynecomastia | Transgenderism | Breast Asymmetry
NCT07342309

Active, not recruiting

Real-World Treatment Patterns and Outcomes in HER2-Altered Metastatic Breast Cancer Patients in the United States

Metastatic Breast Cancer
NCT07148505

Completed

A Study of Real-world Outcomes Among Patients Treated With Ribociclib

Metastatic Breast Cancer
NCT03947151

Completed

Efficacy and Tolerance of an Ovarian Stimulation Protocol Combining Follicle Stimulating Hormone (FSH) and Degarelix Acetate in Female Candidates for Fertility Preservation Before Chemotherapy for Breast Cancer (DEGASTIM)

Invasive Ductal Breast Carcinoma
NCT06176261

Recruiting

DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

Breast Cancer | Breast Cancer Female | Metastatic Triple-Negative Breast Carcinoma | HER2-negative Breast Cancer | HER2 Negative Breast Carcinoma | ER-negative Breast Cancer | ER Positive Breast Cancer
NCT02595905

Completed

Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases

Recurrent Breast Carcinoma | Metastatic Triple-Negative Breast Carcinoma | Metastatic Malignant Neoplasm in the Brain | Stage IV Breast Cancer AJCC v6 and v7 | Metastatic Breast Carcinoma | Metastatic BRCA Hereditary Breast Carcinoma
NCT03568526

Completed

Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer

Peripheral Neuropathy | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7
NCT05770531

Recruiting

Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy

Metastatic Triple-Negative Breast Carcinoma | Metastatic HER2-Negative Breast Carcinoma
NCT05200078

Recruiting

Deep Inspiration Breath-hold Radiotherapy for Left-sided Breast Cancer

Breast Cancer | Cardiac Event

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations